- Home
- RVNC vs BGH Comparison
RVNC vs BGH Comparison
Compare RVNC & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- BGH
- Stock Information
- Founded
- RVNC 1999
- BGH 2012
- Country
- RVNC United States
- BGH United States
- Employees
- RVNC N/A
- BGH N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- RVNC Health Care
- BGH Finance
- Exchange
- RVNC Nasdaq
- BGH Nasdaq
- Market Cap
- RVNC 320.5M
- BGH 318.8M
- IPO Year
- RVNC 2014
- BGH N/A
- Fundamental
- Price
- RVNC $3.67
- BGH $15.93
- Analyst Decision
- RVNC Hold
- BGH
- Analyst Count
- RVNC 9
- BGH 0
- Target Price
- RVNC $7.78
- BGH N/A
- AVG Volume (30 Days)
- RVNC 2.9M
- BGH 61.5K
- Earning Date
- RVNC 02-26-2025
- BGH 01-01-0001
- Dividend Yield
- RVNC N/A
- BGH 10.06%
- EPS Growth
- RVNC N/A
- BGH N/A
- EPS
- RVNC N/A
- BGH N/A
- Revenue
- RVNC $256,945,000.00
- BGH N/A
- Revenue This Year
- RVNC $11.28
- BGH N/A
- Revenue Next Year
- RVNC $27.21
- BGH N/A
- P/E Ratio
- RVNC N/A
- BGH N/A
- Revenue Growth
- RVNC 25.82
- BGH N/A
- 52 Week Low
- RVNC $2.30
- BGH $11.92
- 52 Week High
- RVNC $7.56
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- RVNC 61.28
- BGH 59.03
- Support Level
- RVNC $3.25
- BGH $15.72
- Resistance Level
- RVNC $3.70
- BGH $15.91
- Average True Range (ATR)
- RVNC 0.08
- BGH 0.15
- MACD
- RVNC 0.09
- BGH 0.03
- Stochastic Oscillator
- RVNC 95.52
- BGH 99.98
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.